Quidel | QDEL - Interest Expense On Debt


Quidel reported $5.63B in Interest Expense on Debt for its fiscal quarter ending in March of 2026.





Interest Expense On Debt Change Date
Abbott USD 68M 26M Mar/2026
Agilent USD 25M 0 Mar/2026
Avanos Medical USD 1.9M 100K Dec/2025
Becton, Dickinson and Co. USD 149M 4M Mar/2026
Bruker USD 8.1M 11.9M Dec/2025
Cerus USD 2.33M 96K Jun/2024
Charles River Laboratories USD 26.74M 2.97M Mar/2026
Danaher USD 63M 8M Mar/2026
Haemonetics USD 7.4M 190K Dec/2025
Illumina USD 26M 1000K Dec/2025
IQVIA Holdings USD 192M 1000K Mar/2026
Merit Medical Systems USD 6.53M 162K Mar/2026
Mettler Toledo International USD 17.39M 307K Dec/2025
Myriad Genetics USD 4.4M 600K Dec/2025
Neogen USD 13.9M 356K Dec/2025
OraSure Technologies 1.67M 1.13M Dec/2025
Pacific Biosciences Of California USD 1.74M 1000 Dec/2025
Quidel USD 5.63B 5.58B Mar/2026
Revvity USD 24.72M 1.2M Mar/2026
STAAR Surgical USD 800K 799K Sep/2025
Thermo Fisher Scientific USD 354M 11M Mar/2026
Waters USD 42M 33.38M Mar/2026